Transcript of Earnings Conference Call Q2 FY 2024-25 [UPL]
This edition covers:
- Transcript of Earnings Conference Call Q2 FY 2024-25 [UPL]
- Financial results for the quarter and half year ended September 30, 2024 [PCIL]
- Reappointment of Managing Director of the Company [PCIL]
- Financial results for the quarter and half year ended September 30, 2024 [PIIL]
- Investor Presentation-Q2 FY25 Results [PIIL]
- Change in Management [Bayer]
- Unaudited Financial Results for the quarter and half year ended on September 30, 2024 [Bayer]
- Financial results for the quarter and half year ended on September 30, 2024 [RPL]
- Investor Presentation-Q2FY25 & H1 FY25 [RPL]
- Financial results for the quarter and half year ended on September 30, 2024 [SPCFL]
- Investor Presentation - Q2 and H1 FY25 [SPCFL]
- Earnings Call Transcript [CFCL]
- Financial results for the quarter and half year ended on September 30, 2024 [GNFC]
- Investor Presentation –Q2 FY 24-25 [GNFC]
- Audio recording of conference call with Investors held on 13th November, 2024 [GSFC]
- Financial Results for the quarter ended 30.09.2024 [RCFL]
The complete bulletin is available to subscribers.

